Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study finds medication prevents travelers’ diarrhea

17.05.2005


Antibiotic is effective, lacks side effects and doesn’t provoke resistance in bacteria



An antibiotic can be safely used to prevent attacks of diarrhea that plague millions of globe-trotting vacationers and business travelers, a Houston research team reports this week in the Annals of Internal Medicine. "Our findings show that rifaximin is an ideal drug for prevention of travelers’ diarrhea, an illness that affects an estimated 20 million international travelers each year," said lead author Herbert DuPont, M.D., director of the Center for Infectious Diseases at the University of Texas School of Public Health at Houston and chief of internal medicine at St. Luke’s Episcopal Hospital.

"This medication’s effectiveness, lack of side effects, and its ability to avoid development of resistant strains of bacteria will allow us to change the way we manage this disease," DuPont said.


The clinical trial reported this week followed 210 U.S. students studying Spanish in Mexico during the summer of 2003. Only 14.74 percent of those who took a daily dose of rifaximin for two weeks suffered from diarrhea, while 53.7 percent of those who took placebos came down with the illness, which also includes nausea, vomiting and stomach pain.

Traveler’s diarrhea has been treated for years by antibiotics because it is caused by bacteria found mainly in local food. DuPont’s group previously showed that rifaximin is safe and effective therapy for the illness in studies carried out in Mexico, Peru, India and Kenya. The antibiotic has been available in Europe and elsewhere for years to treat diarrhea. The U.S. Food and Drug Administration approved the antibiotic for treatment of traveler’s diarrhea a year ago.

But would the treatment also prevent the whole unpleasant experience? And, importantly, would it do so without provoking development of a drug-resistant response by the targeted bacteria?

This last point is crucial, DuPont said, because using other antibiotics such as Cipro as a broad preventive measure would hasten development of bacterial resistance, reducing the future value of the antibiotic to treat pneumonia and other life-threatening diseases.

Lab analysis in the study showed rifaximin did not stimulate resistance in the Escherichia coli (E. coli) bacteria that causes the illness in Mexico, a finding consistent with earlier studies. Unlike other antibiotics, which are absorbed and dispersed throughout the body, research has found rifaximin lingers almost exclusively in the gastrointestinal tract, limiting its ability to stimulate resistance.

Researchers are following up with studies of the drug in Asia, where traveler’s diarrhea is caused by other bacteria, such as Shigella, Salmonella and Campylobacter.

And they are following up an earlier finding that 10 percent of those who get traveler’s diarrhea develop the more serious irritable bowel syndrome. "If it is found that this drug prevents irritable bowel syndrome, then rifaximin prevention of travelers’ diarrhea will go from a good idea to a critical health safeguard," DuPont said.

Co-authors with DuPont, who is also a clinical professor of infectious diseases at Baylor College of Medicine, are: Zhi-Dong Jiang, Ph.D., assistant professor of infectious diseases in the UT School of Public Health; Pablo Okhuysen, M.D., and Charles Ericsson, M.D., professors of infectious diseases at the UT Medical School at Houston; Francisco Javier de la Cabada, M.D., professor of infectious diseases and internal medicine at the University of Guadalajara: Shi Ke, M.D. assistant professor of experimental diagnostic imaging, UT M. D. Anderson Cancer Center; Margaret DuPont, research associate in infectious diseases, UT Medical School at Houston; Francisco Martinez-Sandoval, M.D., dean of the international program at Universidad de Guadalajara.

Scott Merville | EurekAlert!
Further information:
http://www.uth.tmc.edu

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>